VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Champions Oncology, Inc. (CSBR) Total Return Calculator with Dividends Reinvested

Champions Oncology, Inc.

Popular:

The total return for Champions Oncology, Inc. (CSBR) stock is +3.10% over the past 12 months. So far it's down 10.06% this year. The 5-year total return is -40.93%, meaning $10,000 invested in CSBR stock 5 years ago would be worth $5,907 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in CSBR 1 year ago, it would be worth $10,118 today — you'd have gained $118.

With Dividends Reinvested$10,118+1.18%

Price Only (No DRIP)$10,118+1.18%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in CSBR

1Y$10,310+$310 (+3.1%)3.1% CAGR

3Y$12,937+$2,937 (+29.4%)9.0% CAGR

5Y$5,907-$4,093 (-40.9%)-10.0% CAGR

10Y$14,790+$4,790 (+47.9%)4.0% CAGR

15Y$4,622-$5,378 (-53.8%)-5.0% CAGR

20Y$8,319-$1,681 (-16.8%)-0.9% CAGR

30Y$8,320-$1,680 (-16.8%)-0.6% CAGR

Champions Oncology, Inc. did not pay dividends during this period. Total return = price return.

Loading CSBR total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-10.06%	—	-10.06%	—	$8,994
1Y	+3.10%	3.10%	+3.10%	—	$10,310
3Y	+29.37%	8.96%	+29.37%	—	$12,937
5Y	-40.93%	-9.99%	-40.93%	—	$5,907
10Y	+47.90%	3.99%	+47.90%	—	$14,790
15Y	-53.78%	-5.02%	-53.78%	—	$4,622
20Y	-16.81%	-0.92%	-16.81%	—	$8,319
30Y	-16.80%	-0.61%	-16.81%	—	$8,320

Risk & Highlights

Best Year+300.00%2013

Worst Year-60.00%2012

Max Drawdown-35.80%2025-07-09 → 2026-03-10

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-10.59%	-10.59%	—	+0.41%	-11.0pp
2025	-15.73%	-15.73%	—	+16.64%	-32.4pp
2024	+48.01%	+48.01%	—	+24.00%	+24.0pp
2023	+27.15%	+27.15%	—	+24.81%	+2.3pp
2022	-46.82%	-46.82%	—	-19.95%	-26.9pp

CSBR underperformed the S&P 500 by 27.27pp over the past year (+3.10% vs +30.37%).

Loading summary...

CSBR Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
CSBRChampions Oncology, Inc.	$84M	-2.4%	-10.1%	+3.1%	—	+29.4%	-40.9%	+47.9%
IMVTImmunovant, Inc.	$5.5B	+10.6%	+5.1%	+96.1%	—	+40.9%	+62.4%	+173.6%
CASICASI Pharmaceuticals, Inc.	$2M	—	-81.6%	-91.2%	—	-94.0%	-99.1%	-99.0%
TPVGTriplePoint Venture Growth BDC Corp.	$243M	+17.7%	-6.3%	+19.3%	+17.2pp	-3.4%	-13.5%	+93.3%
IDXXIDEXX Laboratories, Inc.	$45.4B	-0.5%	-14.6%	+17.6%	—	+17.9%	+5.1%	+556.2%
NTRANatera, Inc.	$31.2B	+5.0%	-3.9%	+37.3%	—	+314.0%	+115.9%	+2089.4%
EXASExact Sciences Corporation	$20.0B	—	+3.1%	+96.9%	—	+53.0%	+0.4%	+1669.1%
AGENAgenus Inc.	$132M	-7.6%	+16.1%	+27.1%	—	-88.2%	-93.9%	-94.3%
CRLCharles River Laboratories International, Inc.	$9.0B	+7.3%	-10.1%	+32.8%	—	-4.2%	-46.9%	+119.2%
IQVIQVIA Holdings Inc.	$30.3B	+4.7%	-20.7%	+16.5%	—	-5.9%	-23.8%	+166.5%
MEDPMedpace Holdings, Inc.	$12.2B	-15.7%	-24.9%	+42.9%	—	+104.6%	+159.4%	+1442.7%

Compare:CSBR vs IMVT CSBR vs CASI CSBR vs TPVG CSBR vs IMVT vs CASI

About CSBR Dividend Returns

Champions Oncology, Inc. (CSBR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of CSBR over the past year?

Champions Oncology, Inc. (CSBR) delivered a return of 3.10% over the past year. Since CSBR does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in CSBR be worth today?

A $10,000 investment in Champions Oncology, Inc. one year ago would be worth $10,310 today, representing a gain of $310.

Q3Does CSBR pay dividends?

Champions Oncology, Inc. (CSBR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CSBR, the total return equals the price-only return.

Q4Did CSBR beat the S&P 500?

No, Champions Oncology, Inc. (CSBR) underperformed the S&P 500 by 27.27 percentage points over the past year. CSBR delivered a total return of 3.10%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed CSBR by 27.27pp during this period.

Q5What is CSBR's worst drawdown?

Champions Oncology, Inc. (CSBR) experienced a maximum drawdown of -35.80% over the past year, declining from its peak on 2025-07-09 to its trough on 2026-03-10. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is CSBR's long-term total return over 10, 20, or 30 years?

Here are Champions Oncology, Inc. (CSBR)'s long-term returns with dividends reinvested. Over 10 years, the total return is 47.9% (4.0% CAGR) — $10,000 would have grown to $14,790. Over 20 years: -16.8% total return (-0.9% CAGR) — $10,000 → $8,319. Over 30 years: -16.8% total return (-0.6% CAGR) — $10,000 → $8,320. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was CSBR's best and worst year?

Champions Oncology, Inc.'s best calendar year was 2013 with a total return of 300.0%. Its worst year was 2012 with a total return of -60.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 360.0 percentage points.